The details left outside the headline.
34 distinct brands · Public-record reviews
Start with the organization. Follow its actual product, service and care documents. Each full review keeps the supported statement beside the details the records leave open.
Some records name tirzepatide; others describe broader weight care. The scope beside each brand identifies what the reviewed documents establish.
34 brand reviews.
Online care record
Dedicated compounded tirzepatide microdosing record; advertised price and commitment differ across pages, and individual prescribing remains conditional.
Read the dedicated product page, shared offer and regulatory records without treating any one document as the complete clinical or financial answer.
Read this brand’s full review →Online care record
Broader primary-care weight management without a named tirzepatide preparation or verified microdose service; membership and scheduled care have different qualifications.
Keep broader primary-care weight management, annual membership, qualified prescribing encounters and regional Seniors coverage distinct.
Read this brand’s full review →Online care record
Administrative telehealth platform with conditional compounded-tirzepatide discussion; provider, pharmacy, personal product and applicable coverage remain unverified.
Follow the administrative-service definition through conditional prescribing, remote-care limits and provider-specific payer exceptions.
Read this brand’s full review →Online care record
Broader Metabolic Reset includes tirzepatide and excludes compounds; outcome and direct/company-plan record scopes remain unresolved.
The no-compounds policy is explicit. Outcome versions and direct-versus-company eligibility wording remain unresolved.
Read this brand’s full review →Health system record
Broader medical weight management; the named endocrine center lists Northeast Ohio locations.
Separate the broad medical-weight-management service from the named endocrine center, its regional locations and its shared appointments.
Read this brand’s full review →Online care record
Conditional virtual prescribing names Zepbound and Mounjaro; visit charges, location-dependent delivery and completed-care refund rules do not verify an individual medicine order.
Read conditional medicine examples, encounter fees, untested delivery displays and the exact completed-care and refund definitions.
Read this brand’s full review →Health system record
Duke Lifestyle and Weight Management Center in Durham, North Carolina; published virtual and in-person services remain qualified.
Connect the named Durham clinic with Duke’s medical-weight-loss description while separating clinical services, participant reports and exact medicine evidence.
Read this brand’s full review →Online care record
Conditional weight care with compounded-tirzepatide guarantee language; current personal product and microdose inventory are not established by the menu or contract.
Preserve the printed menu, mixed self-reports, Wegovy study attribution and the guarantee's narrower medicine and refund definitions.
Read this brand’s full review →Online care record
Physician-led weight care requires recent PCP records and conditionally prescribes FDA-approved medicines, including named Zepbound.
Follow the recent-visit requirement, medical release and conditional medicine descriptions through a physician-led service.
Read this brand’s full review →Online care record
Broader Found weight care names branded and compounded tirzepatide; the dedicated microdose card names compounded semaglutide.
Read the broad medicine toolkit, annual-plan offer and dedicated semaglutide microdose card as distinct documents.
Read this brand’s full review →Online care record
Broader brand-name and compound tirzepatide options; dedicated Daily Oral/Daily Nasal microdose record identifies semaglutide, with clinical outcomes unverified.
Read the broader tirzepatide catalog beside the dedicated semaglutide product and the footnote defining fulfillment success.
Read this brand’s full review →Online care record
Dedicated compounded oral-tirzepatide advertisement has unresolved semaglutide assessment and injectable-semaglutide outcome wording.
The product heading, eligibility block and injectable-semaglutide outcome reference do not identify one consistent intervention.
Read this brand’s full review →Online care record
Broader weight care naming Mounjaro and Zepbound conditionally; no dedicated tirzepatide microdose offer established.
Read which document names the medicine, which promises access, and which leaves the final clinical decision open.
Read this brand’s full review →Online care record
Explicit compounded tirzepatide microdosing offer; program membership, clinical selection and medicine evidence are separate records.
Separate the microdosing price table, membership agreement and medication-policy references before assuming they describe one complete promise.
Read this brand’s full review →Online care record
Compounded GLP-1 microdose injections; public product description, quality claims, care process and return policy.
Ivy names two ingredients under one microdose offer. Its price, quality statements and customer survey each answer a different question.
Read this brand’s full review →Health system record
Healthful Eating, Activity & Weight Program; initial in-person and later video or clinic visits are published descriptions, with indexed access limits.
Read the Healthful Eating, Activity & Weight Program’s service description with its original blocked-direct and indexed-access limitations visible.
Read this brand’s full review →Online care record
Custom compounded tirzepatide and conditional Zepbound are documented in distinct plans; charges, formulation and pharmacy jurisdiction require the selected arrangement.
Keep custom-plan prepayment, the medicine-excluding brand service and consultation charges attached to their actual records.
Read this brand’s full review →Online care record
Broader affiliated weight care names Zepbound conditionally; program access and medication coverage differ, with primary/secondary government-related exclusions.
Read the weight-care section, affiliated-provider roles and primary or secondary government-coverage exclusions in their own scope.
Read this brand’s full review →Online care record
Compounded semaglutide and tirzepatide; confirm the exact prescribed preparation
Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
Read this brand’s full review →Online care record
Compounded semaglutide and tirzepatide
Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
Read this brand’s full review →Health system record
Bariatric Center in Jacksonville; wider Mayo access material has a separate scope.
Read the Jacksonville first-appointment description beside Mayo’s broader obesity navigation without exporting a local medicine example across the system.
Read this brand’s full review →Online care record
Broad weight care names compounded tirzepatide and approved-brand examples; clinician selection and actual dispensing identity remain unresolved.
Read the medicine categories, independent-practice definition, pharmacy-choice terms and separate membership and dispatch records.
Read this brand’s full review →Online care record
Named compounded tirzepatide Microdose Plus program; contract versions, state availability and ingredient-specific evidence require their own records.
Follow the exact Plus program across the support page, cost explanation, shared promotion and refund policy.
Read this brand’s full review →Health system record
Adult Complex Weight Management Clinic and separately scoped Western Suburbs nonsurgical program; no verified current tirzepatide catalogue.
Keep the adult Complex Weight Management Clinic, its Lifestyle FAQ and the separate Western Suburbs program in their own documentary scopes.
Read this brand’s full review →Health system record
Weight Management Program across New York City and Long Island; conditional obesity-medication record names Zepbound, with separate adolescent services.
Connect the New York City and Long Island program description with the obesity-medication page, preserving product identity and population boundaries.
Read this brand’s full review →Online care record
Primary-care weight management names tirzepatide brands; the normal-BMI new-patient exclusion has a documented-previous-obesity exception.
Read the primary-care setting, previous-obesity records and separate prescription and coverage decisions.
Read this brand’s full review →Online care record
Conditional compounded semaglutide and tirzepatide care; dedicated microdose ingredient is not identified, and any microdose period is excluded from the stated warranty.
Distinguish an unnamed microdose ingredient, mixed member observations, batch-testing claims and the twelve-month warranty definition.
Read this brand’s full review →Online care record
Broader weight management naming Zepbound tirzepatide presentations, with conditional prescribing and distinct payment routes.
Zepbound listings, coverage assistance and pharmacy routing describe different stages of an advertised service.
Read this brand’s full review →Online care record
Success by Sesame names conditional Zepbound KwikPen care; milestones concern semaglutide research, and subscription, laboratory and beneficiary limits remain material.
The dedicated service page names Zepbound, assigns milestones to semaglutide research and qualifies subscription costs, labs and access.
Read this brand’s full review →Health system record
Weight Management Program within Digestive Health Center; conditional GLP1 care, with separate online second-opinion service.
Follow the Weight Management Program’s conditional prescribing statement while keeping virtual care and online second opinion in separate records.
Read this brand’s full review →Health system record
Clinical Nutrition Medical Weight Management Program and its maintenance service; no verified GLP1 or microdose catalogue from these records.
Read the Clinical Nutrition program overview and its separate maintenance page without turning medical supervision into a verified GLP1 prescribing offer.
Read this brand’s full review →Online care record
A current-source review of SuperHealthy Rx tirzepatide microdosing: the prescription route and the person responsible for follow-up, billing questions and evidence limits.
Read this brand’s full review →Online care record
Affiliated WeightWatchers Clinic conditionally offers named tirzepatide brands through distinct Med+ and coverage arrangements.
The dedicated page separates clinical services, Med+ access and qualified medicine-coverage arrangements.
Read this brand’s full review →Health system record
Metabolic Health & Weight Loss Program and broader Center for Weight Management; planned 2022 move and remote jurisdictions remain unverified current logistics.
Separate the nonsurgical program, the broader center and its planned 2022 relocation from claims about a current address, medicine catalogue or research-backed offer.
Read this brand’s full review →